Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Lancet Oncol. 2022 Jun 14;23(7):910–918. doi: 10.1016/S1470-2045(22)00251-0

Figure 1. Study CONSORT flow diagram.

Figure 1.

*Under screen failures, reasons for “lesion exclusion” included Gleason score, lesion visibility, calcifications, tumor size, or contact with capsule/extracapsular extension.